Navigation Links
Novexel to Present Four Posters at the 19th European Congress of Clinical Microbiology and Infectious Diseases in Helsinki
Date:5/17/2009

er=FRX'> FRX), solely for North American markets.

Novexel was created in December 2004 as an independent spin-out of the sanofi-aventis (Euronext Paris: SAN, NYSE: SNY) anti-infectives unit. Novexel has a team of 50 employees with significant experience in anti-infective research and development, who are located in Paris, France and Philadelphia, USA.

    [1] Source: IMS Health, MIDAS, 2006-2008

    For further information please contact:
    Novexel
    Gordon Waldron, CFO
    gordon.waldron@novexel.com

    Citigate Dewe Rogerson
    Amber Bielecka/David Dible/Nina Enegren
    Tel.: +44-207-638-95-71
    amber.bielecka@citigatedr.co.uk

'/>"/>
SOURCE Novexel
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Novexels NXL104/ceftazidime Combination Commences Second Phase II Clinical Trial in Hospital Patients With Complicated Intra-Abdominal Infections (cIAIs)
2. Novexels NXL104/ceftazidime Combination Commences Phase II Clinical Trial in Hospital Patients With Complicated Urinary Tract Infections
3. Novexel to Present Five Posters at the Joint Annual Interscience Conference on Antimicrobial Agents and Chemotherapy and the Infectious Disease Society of America (ICAAC/IDSA) Meeting
4. Novexel Reports Positive Phase II Trial Results With NXL103 in Adult Patients With Community Acquired Pneumonia
5. Optimer Pharmaceuticals Presents Results From Fidaxomicin Phase 3 Study for the Treatment of Clostridium difficile Infection
6. Pixantrone Phase 3 Data to be Presented at the 2009 American Society of Clinical Oncology (ASCO) Annual Meeting
7. Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009
8. TYRX Presents Early Clinical Results from AIGISRX(TM) Antibacterial Envelope Retrospective Registry
9. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
10. Autism Studies Presented at Mid-Atlantic Research Consortium Meeting
11. Three Clinical Presentations on Tapentadol Extended Release Tablets for Chronic Pain Featured at 2009 American Pain Society Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... Volcano Corporation (Nasdaq: VOLC ), ... tools - including Fractional Flow Reserve (FFR), Intravascular ... Tomography (OCT) - designed to enhance the diagnosis ... announced today the placement of over 2,500 s5 ... consoles was first launched in April 2006, with ...
(Date:12/15/2009)... CITY, Dec. 15 Sonic Innovations, Inc. ... services and solutions, donated $10,000 to its local ... Dec. 14, 2009. ,, Sonic Innovations President Paul ... Feeding America member, the Utah Food Bank, at ... employees also participated in an office food drive ...
(Date:12/15/2009)... Champions Biotechnology, Inc . (OTC Bulletin Board: ... advanced preclinical platforms and tumor specific data to ... its financial results for the second fiscal quarter ... Company,s financial results are available in the Company,s ... revenues for the second quarter of 2010 were ...
Breaking Medicine Technology:Volcano Announces Installed Base Growth Milestone 2Volcano Announces Installed Base Growth Milestone 3Volcano Announces Installed Base Growth Milestone 4Volcano Announces Installed Base Growth Milestone 5Sonic Innovations, Inc. Donates $10,000 to Feeding America 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 2Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 3Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 4Champions Biotechnology Reports Fiscal 2010 Second Quarter Financial Results 5NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference 14650 1NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference 14650 2Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9 000 Patients Annually 5846 1Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9 000 Patients Annually 5846 2Center for Community Health Opens in Skid Row to Provide Healthcare Services to Nearly 9 000 Patients Annually 5846 3Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 1Neuro Kinetics 26amp 3B Military Researchers in Push To Improve Diagnosis 26amp 3B Treatment of Combat Brain Injuries 5842 2
... May 19 Ikaria Holdings, Inc., a fully,integrated ... completed dosing of its Phase 1a trial for ... The study was a Phase 1, randomized, single ... single bolus injection of IK-1001,in healthy volunteers to ...
... MARSEILLE, France, May 19 IPSOGEN SA (Marseille and ... diagnostic,assays for blood & breast cancers, announced today that ... (MDACC, Houston, TX) will,present the results of two studies ... Meeting, held in Chicago from May 30 to June ...
Other Medicine Technology:Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 2Ikaria Completes Dosing of Phase 1a Clinical Study for IK-1001 (Sodium Sulfide) for Injection 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 2Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 3Ipsogen Announces Three Studies at the American Society of Clinical Oncology (ASCO) Meeting Extending the Utility of the Genomic Grade Index for Predicting Response to Chemotherapy in Breast Cancer 4
(Date:12/16/2009)... The holidays are rapidly approaching and what would be the perfect ... stem cells, of course! Celebrity Beauty Engineer® and Licensed Esthetician Mary ... how to look and feel their best! , ... ... what kind of gift does a person get that special woman ...
(Date:12/15/2009)... SUMMARY: The U.S. Senate today rejected an ... Act that would have helped make prescription drugs ... legal importation of lower priced drugs from abroad. ... by Senators Dorgan, Snowe, McCain, Grassley and Stabenow, ... down the skyrocketing costs of prescription drugs. ,, ...
(Date:12/15/2009)... of coal for lying about taxes in the healthcare bill ... Baucus has earned a place under the "Naughty" column on ... after being caught telling a brazen lie on the ... healthcare bill would not raise taxes. ,, Speaking on ... " I have also heard ...
(Date:12/15/2009)... levels of leptin associated with lower dementia risk, research ... blood levels of leptin, a hormone that regulates appetite, ... "Hopefully, in 10 or 15 years this may be ... the risk of Alzheimer,s disease," said senior study author ... Boston University School of Medicine. "Or it may be ...
(Date:12/15/2009)... will train advocates to be leaders in the ... with support from experts in online learning, the ... Dec. 15 ONE and ... applications for the first-ever "Malaria Griots" program, a ... participants to become leaders in the fight against ...
Breaking Medicine News(10 mins):Health News:New Online Beauty Store Suggests Stem Cells for the Woman Who Has Everything 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 2Health News:AARP Disappointed By Senate Vote Against Lower Prescription Drug Prices 3Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 2Health News:ATR: Baucus Earns Place on 2009 "Naughty" List 3Health News:Fat Hormone May Protect Against Alzheimer's 2Health News:Fat Hormone May Protect Against Alzheimer's 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 2Health News:ONE and Malaria No More Launch 'Malaria Griots' 3Health News:ONE and Malaria No More Launch 'Malaria Griots' 4
... Crosland to Integrate 1929 Paterson Wing into Retail, Office ... Crosland LLC has won exclusive ... Martha Jefferson Hospital ,s 14 acres of property ... nationwide search drew interest from 25 groups and formal ...
... a similar drop in strokes, study finds , , FRIDAY, April ... hormone replacement therapy (HRT) to treat menopause symptoms has been ... among American women, a new study finds. , But ... noted. , Hormone replacement therapy was widely used to treat ...
... Hope Considered ,Too Important Not To Be Heard,SAN MATEO, ... that "Light of Hope: Help for Children with Autism," ... debut internationally on Friday, April 24, Saturday, April 25 ... during the final week of World Autism Awareness ...
... Completing CE Mark, Application for the ... TSX Venture Exchange: NVC,VANCOUVER, April 24 /PRNewswire-FirstCall/ - Neovasc ... a previously announced non-brokered private placement of approximately 9.52 ... for aggregate gross proceeds of $2.0 million. The proceeds ...
... Radioembolisation with Yttrium-90 (Y-90) glass microspheres is a ... HCC portal vein thrombosis, according to new ... Meeting of the European Association for the Study ... to the researchers, these findings create the foundation ...
... HealthYes!™ is bringing its life-saving mobile screening services to ... most medically-advanced, state-of-the-art equipment and techniques to screen its ... abdominal aortic aneurysm, osteoporosis, and peripheral artery disease. ... ...
Other Medicine News:Health News:Crosland Wins RFP for Urban Infill Mixed-Use in Historic Charlottesville 2Health News:Crosland Wins RFP for Urban Infill Mixed-Use in Historic Charlottesville 3Health News:Crosland Wins RFP for Urban Infill Mixed-Use in Historic Charlottesville 4Health News:Lowered HRT Use May Have Cut Heart Attacks 2Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 2Health News:'Light of Hope: Help for Children with Autism' Ground-Breaking Internet Television Event on April 24 to April 26 Co-Sponsored by Internet Software Leaders 3Health News:Neovasc Completes $2 Million Non-Brokered Private Placement 2Health News:Neovasc Completes $2 Million Non-Brokered Private Placement 3Health News:Future for radioembolisation in patients with advanced hepatocellular carcinoma 2Health News:Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth 2Health News:Texas-Based Mobile Health Screening Company Expands into Dallas-Fort Worth 3
... void filler is an extrudable, moldable bone void ... for use anywhere in the skeletal system, including ... resorbable, serving as a temporary scaffolding for new ... visible on X-ray, making healing easier to assess. ...
... a synthetic porous ceramic graft material composed of ... phase that comprises 70% of human bone. TCP ... that allows the attachment of bone forming cells ... within granules as well as between each granule. ...
Schuknecht-Weitlaner retractor, sharp, angled arms....
Weitlaner Beckmann retractor, sharp prongs, SS....
Medicine Products: